Results from CCK8 and cell cycle analyses showed that loss of GSK3α inhibited proliferation ability of NSCLC cells, mediated an increase and a decrease in G0-G1 and G2-M phase ratios, respectively (Fig. 3b–c). The gene discussed is GSK3A; the disease is non-small cell lung carcinoma.